Jan M Middeke
Overview
Explore the profile of Jan M Middeke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Middeke J, Teipel R, Rollig C, Stasik S, Zebisch A, Sill H, et al.
Leuk Lymphoma
. 2021 Jan;
62(6):1432-1440.
PMID: 33399480
We performed a registry-based analysis of 311 AML patients treated with decitabine in a standard of care setting to assess response and survival data with a distinct focus on the...
12.
Miklos U, Strugov V, Lewerin C, Grosicki S, Mazur G, Steurer M, et al.
Br J Haematol
. 2020 Jan;
189(4):689-693.
PMID: 31994178
In 2014, an interim analysis of a phase 3 study was performed to evaluate the effectiveness of ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukaemia (BFR CLL) as compared...
13.
Amberge S, Kramer M, Schrottner P, Heidrich K, Schmelz R, Middeke J, et al.
Bone Marrow Transplant
. 2019 Sep;
55(2):367-375.
PMID: 31534193
Clostridium difficile (CD) infection is the main cause of nosocomial enterocolitis in western countries and in patients undergoing allogeneic hematopoietic stem cell transplantation (alloHCT). Recipients of alloHCT are at high...
14.
Stolzel F, Luer T, Lock S, Parmentier S, Kuithan F, Kramer M, et al.
Haematologica
. 2019 Aug;
105(6):1552-1558.
PMID: 31467130
Extramedullary (EM) disease in patients with acute myeloid leukemia (AML) is a known phenomenon. Since the prevalence of EM AML has so far only been clinically determined on examination, we...
15.
Stasik S, Middeke J, Kramer M, Rollig C, Kramer A, Scholl S, et al.
Haematologica
. 2019 Aug;
105(5):e228-e231.
PMID: 31413097
No abstract available.
16.
Middeke J, Kollinger F, Baldauf H, Stolzel F, Wermke M, von Bonin M, et al.
Biol Blood Marrow Transplant
. 2018 May;
24(9):1947-1951.
PMID: 29793046
Despite recent advances, allogeneic hematopoietic stem cell transplantation (allo-HSCT) continues to be accompanied by a high rate of morbidity and mortality. Several scores have been developed to predict outcome after...
17.
Schetelig J, Link C, Stuhler G, Wagner E, Hanel M, Kobbe G, et al.
Br J Haematol
. 2018 Mar;
184(5):833-836.
PMID: 29528122
No abstract available.
18.
Schmidt J, Rucker-Braun E, Heidrich K, von Bonin M, Stolzel F, Thiede C, et al.
Proteomes
. 2018 Feb;
6(1).
PMID: 29439554
Targeting of leukemic stem cells with specific immunotherapy would be an ideal approach for the treatment of myeloid malignancies, but suitable epitopes are unknown. The comparative proteome-level characterization of hematopoietic...
19.
Heidenreich F, Rucker-Braun E, Walz J, Eugster A, Kuhn D, Dietz S, et al.
Haematologica
. 2017 Aug;
102(11):e460-e464.
PMID: 28838995
No abstract available.
20.
Lal R, Lind K, Heitzer E, Ulz P, Aubell K, Kashofer K, et al.
Blood
. 2017 Mar;
129(18):2587-2591.
PMID: 28258055
No abstract available.